Cargando…

Novel CFHR2-CFHR1 Hybrid in C3 Glomerulopathy Identified by Genomic Structural Variation Analysis

Detalles Bibliográficos
Autores principales:	Sugawara, Yuka, Kato, Hideki, Yoshida, Yoko, Fujisawa, Madoka, Kokame, Koichi, Miyata, Toshiyuki, Akioka, Yuko, Miura, Kenichiro, Hattori, Motoshi, Nangaku, Masaomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895660/ https://www.ncbi.nlm.nih.gov/pubmed/31844814 http://dx.doi.org/10.1016/j.ekir.2019.09.008

Ejemplares similares

CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome
por: Sugawara, Yuka, et al.
Publicado: (2023)

Determining the Population Frequency of the CFHR3/CFHR1 Deletion at 1q32
por: Holmes, Lucy V., et al.
Publicado: (2013)

Associations of CFH Polymorphisms and CFHR1-CFHR3 Deletion with Blood Pressure and Hypertension in Chinese Population
por: Gan, Wei, et al.
Publicado: (2012)

Atypical haemolytic uremic syndrome with refractory multiorgan involvement and heterozygous CFHR1/CFHR3 gene deletion
por: Diep, Jason, et al.
Publicado: (2023)

CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis
por: Piras, Rossella, et al.
Publicado: (2021)

Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome
por: Zipfel, Peter F, et al.
Publicado: (2007)

Atypical HUS Associated with CFH/CFHR-1 Hybrid Gene
por: Negi, Sharon, et al.
Publicado: (2020)

A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry
por: Medjeral-Thomas, Nicholas, et al.
Publicado: (2014)

Complement Factor H-Related Proteins CFHR2 and CFHR5 Represent Novel Ligands for the Infection-Associated CRASP Proteins of Borrelia burgdorferi
por: Siegel, Corinna, et al.
Publicado: (2010)

Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration
por: Lorés-Motta, Laura, et al.
Publicado: (2021)

Regulating complement in the kidney: insights from CFHR5 nephropathy
por: Gale, Daniel P., et al.
Publicado: (2011)

CFHR1 is a potentially downregulated gene in lung adenocarcinoma
por: Wu, Geting, et al.
Publicado: (2019)

Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
por: Ding, Qinglin, et al.
Publicado: (2022)

Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies
por: Münch, Johannes, et al.
Publicado: (2017)

FHR-5 Serum Levels and CFHR5 Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy
por: Garam, Nóra, et al.
Publicado: (2021)

Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome
por: Fujisawa, Madoka, et al.
Publicado: (2018)

Correction to: Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome
por: Fujisawa, Madoka, et al.
Publicado: (2019)

Human Factor H-Related Protein 2 (CFHR2) Regulates Complement Activation
por: Eberhardt, Hannes U., et al.
Publicado: (2013)

Variation in CFHR3 determines susceptibility to meningococcal disease by controlling factor H concentrations
por: Kumar, Vikrant, et al.
Publicado: (2022)

Pathogenic Neisseria Bind the Complement Protein CFHR5 via Outer Membrane Porins
por: Yee, Wearn-Xin, et al.
Publicado: (2022)

CFHR5 Nephropathy in a Greek-Cypriot Australian Family: Ancestry-Informed Precision Medicine
por: Ng, Monica S.Y., et al.
Publicado: (2018)

Case Report: A Rare Truncating Variant of the CFHR5 Gene in IgA Nephropathy
por: Guzzo, Gabriella, et al.
Publicado: (2021)

Atypical hemolytic uremic syndrome: Unique clinical presentation linked to rare CFHR5 mutation
por: Menotti, Sofia, et al.
Publicado: (2021)

Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma
por: Yu, Hongjun, et al.
Publicado: (2022)

Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase
por: Sakurai, Satoko, et al.
Publicado: (2020)

Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration
por: Ansari, Morad, et al.
Publicado: (2013)

Association among Complement Factor H Autoantibodies, Deletions of CFHR, and the Risk of Atypical Hemolytic Uremic Syndrome
por: Jiang, Hong, et al.
Publicado: (2016)

Complement Factor H-Related Protein 4A Is the Dominant Circulating Splice Variant of CFHR4
por: Pouw, Richard B., et al.
Publicado: (2018)

CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome
por: Piras, Rossella, et al.
Publicado: (2023)

Genetic analysis of complement factor H related 5, CFHR5, in patients with age-related macular degeneration
por: Narendra, Umadevi, et al.
Publicado: (2009)

Acquired thrombotic thrombocytopenic purpura with isolated CFHR3/1 deletion—rapid remission following complement blockade
por: Bitzan, Martin, et al.
Publicado: (2018)

Low Complement Factor H-Related 3 (CFHR3) Expression Indicates Poor Prognosis and Immune Regulation in Cholangiocarcinoma
por: Wang, Haoran, et al.
Publicado: (2022)

Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions
por: Hannan, Jonathan P., et al.
Publicado: (2016)

Analysis of Linear Antibody Epitopes on Factor H and CFHR1 Using Sera of Patients with Autoimmune Atypical Hemolytic Uremic Syndrome
por: Trojnár, Eszter, et al.
Publicado: (2017)

LncRNA MIAT enhances systemic lupus erythematosus by upregulating CFHR5 expression via miR-222 degradation
por: Zhang, Yali, et al.
Publicado: (2021)

The miR-590-3p/CFHR3/STAT3 signaling pathway promotes cell proliferation and metastasis in hepatocellular carcinoma
por: Wan, Zhongzhong, et al.
Publicado: (2022)

Atypical Hemolytic Uremic Syndrome With the p.Ile1157Thr C3 Mutation Successfully Treated With Plasma Exchange and Eculizumab: A Case Report
por: Saito, Daiki, et al.
Publicado: (2019)

A miR-1207-5p Binding Site Polymorphism Abolishes Regulation of HBEGF and Is Associated with Disease Severity in CFHR5 Nephropathy
por: Papagregoriou, Gregory, et al.
Publicado: (2012)

High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B
por: Pouw, Richard B., et al.
Publicado: (2018)

Correction for: The miR-590-3p/CFHR3/STAT3 signaling pathway promotes cell proliferation and metastasis in hepatocellular carcinoma
por: Wan, Zhongzhong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uff4iobsijj307d03rbu12ot7o